Ofatumumab |
| カタログ番号GC65498 |
Ofatumumab (Arzerra) は、CD20 発現 B リンパ球において抗体依存性細胞媒介性細胞傷害および補体依存性細胞傷害を誘発する完全ヒト抗 CD20 モノクローナル抗体です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 679818-59-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Ofatumumab (Arzerra) is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes[1].
[1]. Sanford M, McCormack PL. Ofatumumab. Drugs. 2010;70(8):1013-1019.
Review for Ofatumumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Ofatumumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *